Discovery of a Novel DDRs Kinase Inhibitor XBLJ-13 for the Treatment of Idiopathic Pulmonary Fibrosis

Ying Dong,Bi-xi Tang,Qi Wang,Li-wei Zhou,Cong Li,Xuan Zhang,Dan-dan Sun, Xin Sun,Xue-mei Zhang,Bing Xiong,Jia Li,Hong Shi,Dan-qi Chen,Yi Zang

Acta pharmacologica Sinica（2021）

Cited 6|Views26
No score
Key words
idiopathic pulmonary fibrosis,DDRs,kinase inhibitor,indazole derivatives,XBLJ-13,nintedanib,bleomycin-induced pulmonary fibrosismouse model
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined